Clinical development of the toll-like receptor 9 agonist DIMS0150 in chronic active ulcerative colitis patients

Knittel Thomas

首页> 外文期刊>Chimica oggi: international journal of chemistry and biotechnology >Clinical development of the toll-like receptor 9 agonist DIMS0150 in chronic active ulcerative colitis patients

【24h】

Clinical development of the toll-like receptor 9 agonist DIMS0150 in chronic active ulcerative colitis patients

机译：Toll样受体9激动剂DIMS0150在慢性活动性溃疡性结肠炎患者中的临床开发

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Chimica oggi: international journal of chemistry and biotechnology 》 |2016年第2suppla期| 共1页
作者
Knittel Thomas;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类化学 ;
关键词
Toll-like receptors; ulcerative colitis; therapy; oligonucleotide;

机译：Toll样受体;溃疡性结肠炎;治疗;寡核苷酸;

相似文献

外文文献
中文文献
专利

1. Clinical development of the toll-like receptor 9 agonist DIMS0150 in chronic active ulcerative colitis patients [J] . Knittel Thomas Chimica oggi: international journal of chemistry and biotechnology . 2016 ,第2Suppla期

机译：Toll样受体9激动剂DIMS0150在慢性活动性溃疡性结肠炎患者中的临床开发
2. Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity. [J] . Eugen Musch, Tamim Lutfi, Petra von Stein, Inflammatory bowel diseases . 2013 ,第2期

机译：用Toll样受体激动剂DIMS0150进行的局部治疗可能通过恢复糖皮质激素的敏感性而持久缓解慢性活动性溃疡性结肠炎患者的症状。
3. Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients [J] . Nikolai V Kuznetsov, Arezou Zargari, Alexander W Gielen, BMC Gastroenterology . 2014 ,第1期

机译：生物标记物可以预测溃疡性结肠炎患者对DIMS0150 a Toll样受体9激动剂的潜在临床反应
4. Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial [C] . Controlled Release Society annual meeting . 2004

机译：同步治疗显着减少了活性溃疡性结肠炎患者的炎症和临床评分的分子标记;随机对照试验
5. Investigating the Clinical Utility of the Gastrointestinal Microbiome in Ulcerative Colitis. [D] . Mar, Jordan Samuel. 2016

机译：调查溃疡性结肠炎中胃肠道微生物组的临床效用。
6. Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients [O] . Nikolai V Kuznetsov, Arezou Zargari, Alexander W Gielen, 2014

机译：生物标记物可以预测溃疡性结肠炎患者对DIMS0150 a Toll样受体9激动剂的潜在临床反应
7. Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients [O] . Nikolai V Kuznetsov, Arezou Zargari, Alexander W Gielen, 2014

机译：生物标记物可以预测溃疡性结肠炎患者对DIMS0150 a Toll样受体9激动剂的潜在临床反应

Clinical development of the toll-like receptor 9 agonist DIMS0150 in chronic active ulcerative colitis patients

著录项

相似文献

相关主题

期刊订阅